oxytetracycline

oxytetracycline is a lipid of Polyketides (PK) class. Oxytetracycline is associated with abnormalities such as Infection, X-linked centronuclear myopathy, Bacterial Infections, Heart failure and Onchocerciasis. The involved functions are known as Anabolism, physiological aspects, Transcription, Genetic, Fermentation and Transcriptional Activation. Oxytetracycline often locates in Chromosomes, Flank (surface region), Entire bony skeleton, Bone Marrow and Body tissue. The associated genes with oxytetracycline are Polypeptides, Homologous Gene, Gene Clusters, Locus and CYCS gene. The related lipids are LH 1 and Lipid Peroxides. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of oxytetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with oxytetracycline?

oxytetracycline is suspected in Infection, Helminthiasis, Nodule, Bacterial Infections, Yeast infection, pathologic fistula and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with oxytetracycline

MeSH term MeSH ID Detail
Bacteremia D016470 9 associated lipids
Helicobacter Infections D016481 21 associated lipids
Ehrlichiosis D016873 2 associated lipids
Encephalitozoonosis D016890 2 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Primate Diseases D018419 2 associated lipids
Parasitemia D018512 5 associated lipids
Vaginal Discharge D019522 2 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Moraxellaceae Infections D045828 3 associated lipids
Pneumonia of Calves, Enzootic D048089 2 associated lipids
Seroma D049291 2 associated lipids
Fractures, Bone D050723 4 associated lipids
Vascular Malformations D054079 1 associated lipids
Digital Dermatitis D058066 3 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 137

PubChem Associated disorders and diseases

What pathways are associated with oxytetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with oxytetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with oxytetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with oxytetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with oxytetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with oxytetracycline?

Disease model

Disease model are used in the study 'A molecular ecological approach to the detection and designation of the etiological agents of a model polymicrobial disease.' (Antiabong JF et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with oxytetracycline

Download all related citations
Per page 10 20 50 100 | Total 5138
Authors Title Published Journal PubMed Link
Palmer GH et al. Absorption in calves of amoxicillin, ampicillin, and oxytetracycline given in milk replacer, water, or an oral rehydration formulation. 1983 Am. J. Vet. Res. pmid:6824227
Magonigle RA et al. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis. 1978 Am. J. Vet. Res. pmid:697150
Toutain PL and Raynaud JP Pharmacokinetics of oxytetracycline in young cattle: comparison of conventional vs long-acting formulations. 1983 Am. J. Vet. Res. pmid:6881660
Kuttler KL and Simpson JE Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomized calves. 1978 Am. J. Vet. Res. pmid:629473
George LW et al. Effectiveness of two benzathine cloxacillin formulations for treatment of naturally occurring infectious bovine keratoconjunctivitis. 1989 Am. J. Vet. Res. pmid:2774340
Bretzlaff KN et al. Distribution of oxytetracycline in the healthy and diseased postpartum genital tract of cows. 1983 Am. J. Vet. Res. pmid:6869979
Bretzlaff KN et al. Distribution of oxytetracycline in genital tract tissues of postpartum cows given the drug by intravenous and intrauterine routes. 1983 Am. J. Vet. Res. pmid:6869980
Kuttler KL Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle. 1983 Am. J. Vet. Res. pmid:6869997
George LW et al. Comparison of two oxytetracycline formulations in the treatment of laboratory-induced pasteurellosis of pigs. 1983 Am. J. Vet. Res. pmid:6870001
Bowen JM and McMullan WC Influence of induced hypermagnesemia and hypocalcemia on neuromuscular blocking property of oxytetracycline in the horse. 1975 Am. J. Vet. Res. pmid:1147343
YODER HW and PACKER RA Bovine blood serum concentrations of terramycin (Oxytetracycline) following intravenous and intramuscular administration. 1954 Am. J. Vet. Res. pmid:13171501
Kerwin SC et al. Effect of hyperbaric oxygen treatment on incorporation of an autogenous cancellous bone graft in a nonunion diaphyseal ulnar defect in cats. 2000 Am. J. Vet. Res. pmid:10850847
Lubbers BV et al. Effects of two simulated oxytetracycline dosing regimens on horizontal transfer of antimicrobial resistance plasmids in an in vitro pharmacodynamic model. 2011 Am. J. Vet. Res. pmid:21728847
Oukessou M et al. Pharmacokinetics and local tolerance of a long-acting oxytetracycline formulation in camels. 1992 Am. J. Vet. Res. pmid:1416372
byford RL et al. Chemoprophylaxis of vector-borne anaplasmosis with sustained-release boluses. 1981 Am. J. Vet. Res. pmid:7340579
Larson VL and Stowe CM Plasma and tissue concentrations of oxytetracycline in the horse after intravenous administration. 1981 Am. J. Vet. Res. pmid:7340586
Fugler LA et al. Plasma matrix metalloproteinase activity in horses after intravenous infusion of lipopolysaccharide and treatment with matrix metalloproteinase inhibitors. 2013 Am. J. Vet. Res. pmid:23438126
Fielding CL et al. Evaluation of potential predictor variables for PCR assay diagnosis of Anaplasma phagocytophilum infection in equids in Northern California. 2018 Am. J. Vet. Res. pmid:30085857
Edmondson AJ et al. Survival analysis for evaluation of corneal ulcer healing times in calves with naturally acquired infectious bovine keratoconjunctivitis. 1989 Am. J. Vet. Res. pmid:2764337
Ames TR and Patterson EB Oxytetracycline concentrations in plasma and lung of healthy and pneumonic calves, using two oxytetracycline preparations. 1985 Am. J. Vet. Res. pmid:3909863
Button C and Mülders MS Effects of oxytetracycline in propylene glycol, oxytetracycline in saline solution, and propylene glycol alone on blood ionized calcium and plasma total calcium in sheep. 1984 Am. J. Vet. Res. pmid:6476580
Malatinszky I Two possibilities of further reduction in mortality from tuberculosis. 1967 Am. Rev. Respir. Dis. pmid:6018714
Ashegyi B and Malatinszky I Bronchial pulmonary disease associated with tuberculous lymph nodes. 1968 Am. Rev. Respir. Dis. pmid:5647212
Ayvazian LF et al. Erythrokinetic studies during antimicrobial therapy in pulmonary emphysema. 1969 Am. Rev. Respir. Dis. pmid:5810804
Albert WC and Inkley SR The efficacy of steroid therapy in the treatment of experimental kerosene pneumonitis. 1968 Am. Rev. Respir. Dis. pmid:5683485
CONN HO et al. ETHIONAMIDE-INDUCED HEPATITIS. A REVIEW WITH A REPORT OF AN ADDITIONAL CASE. 1964 Am. Rev. Respir. Dis. pmid:14221666
PHILLIPS S RELAPSE IN TREATED CASES OF PULMONARY TUBERCULOSIS. I. THREE-YEAR FOLLOW-UP OF 312 PATIENTS DISCHARGED FROM THE HOSPITAL WITH MEDICAL APPROVAL, 1947-1954. 1964 Am. Rev. Respir. Dis. pmid:14178617
BUMBALO TS et al. Pinworm infection (enterobiasis) in children; a comparative study of four oxyuricides. 1953 AMA Am J Dis Child pmid:13103773
BALER GR Oxytetracycline intramuscular in the treatment of early syphilis. 1956 AMA Arch Derm pmid:13312644
BAREFOOT SW Oxytetracycline hydrochloride-polymyxin B sulfate topical powder. 1959 AMA Arch Derm pmid:13636430
STRITZLER C and FRANK L Topical hydrocortisone-oxytetracycline therapy. 1955 AMA Arch Derm pmid:14375396
SNYDER W Terramycin therapy of eczema vaccinatum; report of a case. 1951 AMA Arch Derm Syphilol pmid:14867923
NIEDELMAN ML Molluscum contagiosum treated with oxytetracycline (terramycin). 1953 AMA Arch Derm Syphilol pmid:13007184
MOPPER C Terramycin therapy of molluscum contagiosum. 1952 AMA Arch Derm Syphilol pmid:14914183
TSCHAN DN and WRIGHT CS Safety of systemic oxytetracycline (terramycin) therapy following or with topical therapy. 1954 AMA Arch Derm Syphilol pmid:13147576
ZELIGMAN I and SINESI SJ Carbuncle caused by Gaffkya tetragena treated with oxytetracycline (terramycin). 1953 AMA Arch Derm Syphilol pmid:13091374
WRIGHT CS and TSCHAN DN Local oxytetracycline (terramycin) therapy of skin infections. 1953 AMA Arch Derm Syphilol pmid:13029894
FERGUSON BC and TYLER MD Edema and hypoproteinemia following diarrhea associated with oxytetracycline therapy. 1954 AMA Arch Intern Med pmid:13196730
WOMACK CR et al. Terramycin therapy of urinary tract infections. 1952 AMA Arch Intern Med pmid:14884789
MAGILL GB and KILLOUGH JH Oxytetracycline-streptomycin therapy in brucellosis due to Brucella melitensis. 1953 AMA Arch Intern Med pmid:13016039
BATEMAN JC et al. Fatal complications of intensive antibiotic therapy in patients with neoplastic disease. 1952 AMA Arch Intern Med pmid:12996105
KNIGHT V et al. Terramycin in treatment of human brucellosis. 1951 AMA Arch Intern Med pmid:14829089
DI CAPRIO JM and RANTZ LA Effects of terramycin on the bacterial flora of the bowel in man. 1950 AMA Arch Intern Med pmid:14770585
MITSUI Y et al. Terramycin in the treatment of trachoma. 1951 AMA Arch Ophthalmol pmid:14868042
DOUVAS NG et al. Role of terramycin in ophthalmology. 1951 AMA Arch Ophthalmol pmid:14902193
CANNON EJ et al. Studies on the intraocular penetration and toxicity of terramycin. 1952 AMA Arch Ophthalmol pmid:14902207
FOLBRE TW et al. Rhinoscleroma successfully treated with oxytetracycline (terramycin). 1954 AMA Arch Otolaryngol pmid:13196799
BELDING HH Acute perforated diverticulitis of the sigmoid colon with generalized peritonitis. 1957 AMA Arch Surg pmid:13410323
REISS E et al. Terramycin in treatment of peritonitis. 1952 AMA Arch Surg pmid:14877394
MATHIEU PL Comparison study: silver nitrate and oxytetracycline in newborn eyes; a comparison of the incidence of conjunctivitis following the instillation of silver nitrate or oxytetracycline into the eyes of newborn infants. 1958 AMA J Dis Child pmid:13532153